

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.01670286 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01670286 |
| 3 | response to peptidoglycan (GO:0032494) | 4.61999407 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 4.60037147 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.57103533 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.57103533 |
| 7 | detection of other organism (GO:0098543) | 4.36153228 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.26977786 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.18121898 |
| 10 | detection of external biotic stimulus (GO:0098581) | 4.05819920 |
| 11 | neutrophil activation (GO:0042119) | 4.03028200 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.96099591 |
| 13 | detection of bacterium (GO:0016045) | 3.88334684 |
| 14 | granulocyte activation (GO:0036230) | 3.86820174 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 3.59729206 |
| 16 | detection of biotic stimulus (GO:0009595) | 3.59320596 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.58978112 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.58563515 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50642127 |
| 20 | urea metabolic process (GO:0019627) | 3.48668479 |
| 21 | urea cycle (GO:0000050) | 3.48668479 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.46656521 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44007677 |
| 24 | response to host immune response (GO:0052572) | 3.44007677 |
| 25 | myeloid cell activation involved in immune response (GO:0002275) | 3.39872687 |
| 26 | valine metabolic process (GO:0006573) | 3.39202239 |
| 27 | cysteine metabolic process (GO:0006534) | 3.37075786 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.35368413 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34624096 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.34570820 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 3.34570820 |
| 32 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.33227926 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 3.31794422 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.31794422 |
| 35 | response to interleukin-15 (GO:0070672) | 3.31242257 |
| 36 | regulation of tolerance induction (GO:0002643) | 3.30081379 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 3.27962703 |
| 38 | protein carboxylation (GO:0018214) | 3.27894948 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.27894948 |
| 40 | respiratory burst (GO:0045730) | 3.27365464 |
| 41 | complement activation, alternative pathway (GO:0006957) | 3.27255438 |
| 42 | macrophage activation (GO:0042116) | 3.26524220 |
| 43 | aromatic amino acid family catabolic process (GO:0009074) | 3.25382672 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.22202668 |
| 45 | response to host (GO:0075136) | 3.20719032 |
| 46 | response to host defenses (GO:0052200) | 3.20719032 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.20719032 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.19391463 |
| 49 | leukocyte aggregation (GO:0070486) | 3.18824859 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 3.18132586 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 3.17702192 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.16812753 |
| 53 | indole-containing compound catabolic process (GO:0042436) | 3.16438789 |
| 54 | indolalkylamine catabolic process (GO:0046218) | 3.16438789 |
| 55 | tryptophan catabolic process (GO:0006569) | 3.16438789 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15783140 |
| 57 | urate metabolic process (GO:0046415) | 3.14168316 |
| 58 | B cell mediated immunity (GO:0019724) | 3.12070952 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 3.11877261 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09025011 |
| 61 | dendritic cell migration (GO:0036336) | 3.08290826 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.07019737 |
| 63 | neutrophil mediated immunity (GO:0002446) | 3.05793940 |
| 64 | dendritic cell chemotaxis (GO:0002407) | 3.03957433 |
| 65 | kynurenine metabolic process (GO:0070189) | 3.02179204 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01401341 |
| 67 | tryptophan metabolic process (GO:0006568) | 3.01175019 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.00336215 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99901678 |
| 70 | glyoxylate metabolic process (GO:0046487) | 2.99477195 |
| 71 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.99358186 |
| 72 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.95340992 |
| 73 | regulation of protein activation cascade (GO:2000257) | 2.95015095 |
| 74 | cellular response to type I interferon (GO:0071357) | 2.94764037 |
| 75 | type I interferon signaling pathway (GO:0060337) | 2.94764037 |
| 76 | positive regulation of tolerance induction (GO:0002645) | 2.94559716 |
| 77 | regulation of mast cell activation (GO:0033003) | 2.92902857 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92439621 |
| 79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91950129 |
| 80 | leukocyte degranulation (GO:0043299) | 2.91751177 |
| 81 | regulation of cholesterol homeostasis (GO:2000188) | 2.90385910 |
| 82 | lysine catabolic process (GO:0006554) | 2.90182838 |
| 83 | lysine metabolic process (GO:0006553) | 2.90182838 |
| 84 | regulation of leukocyte degranulation (GO:0043300) | 2.90167044 |
| 85 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.90116544 |
| 86 | response to type I interferon (GO:0034340) | 2.90034009 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.89560669 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 2.89101736 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 2.89101736 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.89101736 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.89101736 |
| 92 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.89101736 |
| 93 | modulation by symbiont of host immune response (GO:0052553) | 2.89101736 |
| 94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88496758 |
| 95 | regulation of complement activation (GO:0030449) | 2.87141736 |
| 96 | T-helper 1 type immune response (GO:0042088) | 2.86840530 |
| 97 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86499285 |
| 98 | bile acid biosynthetic process (GO:0006699) | 2.85003440 |
| 99 | regulation of triglyceride catabolic process (GO:0010896) | 2.84860749 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80631087 |
| 101 | phospholipid efflux (GO:0033700) | 2.80363658 |
| 102 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.79440237 |
| 103 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.78726136 |
| 104 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77366370 |
| 105 | regulation of B cell differentiation (GO:0045577) | 2.77353682 |
| 106 | tolerance induction (GO:0002507) | 2.76805587 |
| 107 | negative regulation of interleukin-17 production (GO:0032700) | 2.76417693 |
| 108 | T cell migration (GO:0072678) | 2.76358876 |
| 109 | positive regulation of mast cell degranulation (GO:0043306) | 2.76136956 |
| 110 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76136956 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.75804442 |
| 112 | homocysteine metabolic process (GO:0050667) | 2.74838775 |
| 113 | serine family amino acid catabolic process (GO:0009071) | 2.74228037 |
| 114 | growth hormone receptor signaling pathway (GO:0060396) | 2.72847845 |
| 115 | ethanol oxidation (GO:0006069) | 2.71845240 |
| 116 | regulation of interferon-alpha production (GO:0032647) | 2.71626285 |
| 117 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70714086 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70621902 |
| 119 | positive regulation of leukocyte degranulation (GO:0043302) | 2.70373206 |
| 120 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.70371007 |
| 121 | macrophage activation involved in immune response (GO:0002281) | 2.70332677 |
| 122 | drug transmembrane transport (GO:0006855) | 2.69932395 |
| 123 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.69825255 |
| 124 | defense response to protozoan (GO:0042832) | 2.69426183 |
| 125 | B cell receptor signaling pathway (GO:0050853) | 2.67914852 |
| 126 | amino-acid betaine metabolic process (GO:0006577) | 2.67800154 |
| 127 | negative thymic T cell selection (GO:0045060) | 2.64959676 |
| 128 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.64758602 |
| 129 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.64224281 |
| 130 | positive regulation of type 2 immune response (GO:0002830) | 2.63981270 |
| 131 | negative T cell selection (GO:0043383) | 2.63135125 |
| 132 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62732040 |
| 133 | negative regulation of cholesterol transport (GO:0032375) | 2.62583802 |
| 134 | negative regulation of sterol transport (GO:0032372) | 2.62583802 |
| 135 | negative regulation of fibrinolysis (GO:0051918) | 2.62472975 |
| 136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.62311177 |
| 137 | phospholipid homeostasis (GO:0055091) | 2.61415633 |
| 138 | low-density lipoprotein particle clearance (GO:0034383) | 2.61140010 |
| 139 | complement activation, classical pathway (GO:0006958) | 2.60904745 |
| 140 | high-density lipoprotein particle remodeling (GO:0034375) | 2.57220737 |
| 141 | regulation of cholesterol storage (GO:0010885) | 2.57147954 |
| 142 | plasma lipoprotein particle clearance (GO:0034381) | 2.55274444 |
| 143 | bile acid and bile salt transport (GO:0015721) | 2.54391872 |
| 144 | complement activation (GO:0006956) | 2.53260393 |
| 145 | positive regulation of B cell differentiation (GO:0045579) | 2.52395241 |
| 146 | reverse cholesterol transport (GO:0043691) | 2.50081044 |
| 147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.49967445 |
| 148 | bile acid metabolic process (GO:0008206) | 2.48428902 |
| 149 | drug transport (GO:0015893) | 2.46011628 |
| 150 | ethanol metabolic process (GO:0006067) | 2.43457575 |
| 151 | negative regulation of granulocyte differentiation (GO:0030853) | 2.41695897 |
| 152 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.40835608 |
| 153 | immunoglobulin mediated immune response (GO:0016064) | 2.38989249 |
| 154 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37766726 |
| 155 | 2-oxoglutarate metabolic process (GO:0006103) | 2.36524987 |
| 156 | plasma lipoprotein particle assembly (GO:0034377) | 2.35804608 |
| 157 | response to growth hormone (GO:0060416) | 2.35038726 |
| 158 | acute-phase response (GO:0006953) | 2.34934420 |
| 159 | regulation of fibrinolysis (GO:0051917) | 2.34499380 |
| 160 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.33020003 |
| 161 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.33020003 |
| 162 | cellular modified amino acid catabolic process (GO:0042219) | 2.32618766 |
| 163 | protein-lipid complex assembly (GO:0065005) | 2.32305648 |
| 164 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.31785234 |
| 165 | cellular response to growth hormone stimulus (GO:0071378) | 2.30716989 |
| 166 | neutrophil activation involved in immune response (GO:0002283) | 2.29430605 |
| 167 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.28676206 |
| 168 | serine family amino acid metabolic process (GO:0009069) | 2.28603130 |
| 169 | primary alcohol catabolic process (GO:0034310) | 2.28051237 |
| 170 | tricarboxylic acid metabolic process (GO:0072350) | 2.27702603 |
| 171 | response to laminar fluid shear stress (GO:0034616) | 2.27465480 |
| 172 | glycine metabolic process (GO:0006544) | 2.26539628 |
| 173 | aromatic amino acid family metabolic process (GO:0009072) | 2.26282690 |
| 174 | cellular extravasation (GO:0045123) | 2.26133707 |
| 175 | microglial cell activation (GO:0001774) | 2.25813383 |
| 176 | cholesterol homeostasis (GO:0042632) | 2.25667478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.13125855 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.83295249 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.80943304 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.67882801 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09036746 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03180718 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.02013154 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.92295759 |
| 9 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.69952302 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.68290372 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.66753869 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.59206461 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49900210 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.45635589 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45623738 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43934614 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32360526 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.30997746 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30962698 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30649570 |
| 21 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21294175 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.19248977 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17910035 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.16847349 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10049136 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09270410 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05338916 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.04211859 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.84809846 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83937617 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83057358 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81765103 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77126204 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69375740 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68675779 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68485545 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.67059263 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.65728683 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63197289 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61983556 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61763748 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58765928 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.55066910 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54862955 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54499649 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54431866 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51190353 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48778298 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48428429 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47991365 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47509110 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.45809942 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43986908 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42637402 |
| 55 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38365107 |
| 56 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.37095402 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30271992 |
| 58 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29935424 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28455965 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26276481 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26146061 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24767123 |
| 63 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19082269 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19018423 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18570908 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17304556 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17089359 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16282011 |
| 69 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16235283 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15763156 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15755337 |
| 72 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15502332 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11781921 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10498681 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10270552 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10062047 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09524285 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09512879 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09420942 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09393533 |
| 81 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09370310 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09007992 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08841798 |
| 84 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08410409 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07880569 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07179291 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07170066 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07060785 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05208972 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05070789 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05021068 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04510916 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03953256 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02649159 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00462678 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99027566 |
| 97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98700476 |
| 98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98700476 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97813453 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97657425 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97499615 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97336581 |
| 103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96784865 |
| 104 | MAF_26560356_Chip-Seq_TH2_Human | 0.96395955 |
| 105 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95954640 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95873656 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95599485 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95339179 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94853674 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94697235 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92602288 |
| 112 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92282549 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92067009 |
| 114 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91564591 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91561467 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90955574 |
| 117 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90266608 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89216229 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88271626 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88251800 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86631806 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85956591 |
| 123 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85488855 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85206150 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85108287 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82580111 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82173938 |
| 128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78219020 |
| 129 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76968768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.76287123 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.52258762 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 2.91939914 |
| 4 | MP0009840_abnormal_foam_cell | 2.77223653 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.74315696 |
| 6 | MP0005365_abnormal_bile_salt | 2.69552184 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.63897000 |
| 8 | MP0003436_decreased_susceptibility_to | 2.42433786 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.24908681 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.19771287 |
| 11 | MP0003252_abnormal_bile_duct | 2.18486715 |
| 12 | MP0006082_CNS_inflammation | 2.10322338 |
| 13 | MP0003303_peritoneal_inflammation | 2.06949020 |
| 14 | MP0000685_abnormal_immune_system | 2.06220024 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.96432874 |
| 16 | MP0002254_reproductive_system_inflammat | 1.95662323 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.91567800 |
| 18 | MP0003828_pulmonary_edema | 1.90319816 |
| 19 | MP0008260_abnormal_autophagy | 1.79253240 |
| 20 | MP0003724_increased_susceptibility_to | 1.78950829 |
| 21 | MP0009785_altered_susceptibility_to | 1.78040613 |
| 22 | MP0001790_abnormal_immune_system | 1.73655628 |
| 23 | MP0005387_immune_system_phenotype | 1.73655628 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.73577982 |
| 25 | MP0005671_abnormal_response_to | 1.72519804 |
| 26 | MP0001800_abnormal_humoral_immune | 1.71447986 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.71173482 |
| 28 | MP0002419_abnormal_innate_immunity | 1.70385898 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 1.69690656 |
| 30 | MP0005025_abnormal_response_to | 1.69471525 |
| 31 | MP0004947_skin_inflammation | 1.64827786 |
| 32 | MP0000609_abnormal_liver_physiology | 1.62673085 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.61899032 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.58705448 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.57643531 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.57058788 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.55484968 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.55296890 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.54779784 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.51862746 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.51007013 |
| 42 | MP0002723_abnormal_immune_serum | 1.50358785 |
| 43 | MP0001853_heart_inflammation | 1.49719832 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.46151871 |
| 45 | MP0005332_abnormal_amino_acid | 1.45663478 |
| 46 | MP0008469_abnormal_protein_level | 1.43375535 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.42786619 |
| 48 | MP0005451_abnormal_body_composition | 1.40148294 |
| 49 | MP0008004_abnormal_stomach_pH | 1.38403527 |
| 50 | MP0001873_stomach_inflammation | 1.37307535 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.37307191 |
| 52 | MP0005083_abnormal_biliary_tract | 1.36572641 |
| 53 | MP0001819_abnormal_immune_cell | 1.35788514 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.34727752 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.33987219 |
| 56 | MP0005164_abnormal_response_to | 1.29679241 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.29548294 |
| 58 | MP0004883_abnormal_blood_vessel | 1.29060536 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.27709353 |
| 60 | MP0009278_abnormal_bone_marrow | 1.27563882 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.24128466 |
| 62 | MP0009764_decreased_sensitivity_to | 1.23281109 |
| 63 | MP0002132_abnormal_respiratory_system | 1.22618008 |
| 64 | MP0002405_respiratory_system_inflammati | 1.21989744 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.21719965 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.19759138 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.19352708 |
| 68 | MP0003763_abnormal_thymus_physiology | 1.16100842 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 1.13310077 |
| 70 | MP0002796_impaired_skin_barrier | 1.12511243 |
| 71 | MP0002006_tumorigenesis | 1.12373660 |
| 72 | MP0001881_abnormal_mammary_gland | 1.09915387 |
| 73 | MP0000716_abnormal_immune_system | 1.09853428 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.06271217 |
| 75 | MP0002136_abnormal_kidney_physiology | 1.05958440 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.05099626 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.05016476 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.04651323 |
| 79 | MP0005023_abnormal_wound_healing | 1.04188764 |
| 80 | MP0002398_abnormal_bone_marrow | 1.03845510 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.03603728 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.03603728 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 1.02320155 |
| 84 | MP0009763_increased_sensitivity_to | 1.01159145 |
| 85 | MP0003075_altered_response_to | 1.00455167 |
| 86 | MP0002396_abnormal_hematopoietic_system | 0.99820661 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.99630565 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.99244943 |
| 89 | MP0000598_abnormal_liver_morphology | 0.99200923 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98831938 |
| 91 | MP0002722_abnormal_immune_system | 0.97106482 |
| 92 | MP0003186_abnormal_redox_activity | 0.96008367 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.94833038 |
| 94 | MP0002429_abnormal_blood_cell | 0.93038550 |
| 95 | MP0005390_skeleton_phenotype | 0.92469130 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.92136612 |
| 97 | MP0003091_abnormal_cell_migration | 0.91992056 |
| 98 | MP0005310_abnormal_salivary_gland | 0.91622921 |
| 99 | MP0004381_abnormal_hair_follicle | 0.90749979 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.90495688 |
| 101 | MP0004808_abnormal_hematopoietic_stem | 0.88526814 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.87232674 |
| 103 | MP0000858_altered_metastatic_potential | 0.87077374 |
| 104 | MP0000343_altered_response_to | 0.86765118 |
| 105 | MP0003195_calcinosis | 0.86206514 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.85963373 |
| 107 | MP0004510_myositis | 0.84173018 |
| 108 | MP0005166_decreased_susceptibility_to | 0.83772407 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.82458554 |
| 110 | MP0000604_amyloidosis | 0.81602458 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.80972262 |
| 112 | MP0003448_altered_tumor_morphology | 0.80763747 |
| 113 | MP0005670_abnormal_white_adipose | 0.80662045 |
| 114 | MP0001764_abnormal_homeostasis | 0.80308271 |
| 115 | MP0003795_abnormal_bone_structure | 0.79226140 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.79100486 |
| 117 | MP0002928_abnormal_bile_duct | 0.78993009 |
| 118 | MP0006054_spinal_hemorrhage | 0.78426889 |
| 119 | MP0003866_abnormal_defecation | 0.77309167 |
| 120 | MP0001851_eye_inflammation | 0.76958106 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.75551798 |
| 122 | MP0002009_preneoplasia | 0.75434998 |
| 123 | MP0000249_abnormal_blood_vessel | 0.73419073 |
| 124 | MP0000490_abnormal_crypts_of | 0.67860976 |
| 125 | MP0003690_abnormal_glial_cell | 0.67566017 |
| 126 | MP0005165_increased_susceptibility_to | 0.67242172 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63806656 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.62853196 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.61123598 |
| 130 | MP0000371_diluted_coat_color | 0.60969291 |
| 131 | MP0003045_fibrosis | 0.58386455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.97868406 |
| 2 | Complement deficiency (HP:0004431) | 4.59484541 |
| 3 | Optic neuritis (HP:0100653) | 4.51008130 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.51008130 |
| 5 | Stomatitis (HP:0010280) | 4.36956902 |
| 6 | T lymphocytopenia (HP:0005403) | 4.07898955 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.96341419 |
| 8 | Abnormality of T cell number (HP:0011839) | 3.80662448 |
| 9 | Glomerulonephritis (HP:0000099) | 3.73988434 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.73118827 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.64961009 |
| 12 | Abnormality of complement system (HP:0005339) | 3.61448570 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.58653603 |
| 14 | Xanthomatosis (HP:0000991) | 3.58226188 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.53934976 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.52056193 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.45920293 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.40575708 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.28600448 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.28557053 |
| 21 | Obstructive lung disease (HP:0006536) | 3.28557053 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.25371745 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.23744569 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.18658074 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.10900430 |
| 26 | Meningitis (HP:0001287) | 3.10757468 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.09020370 |
| 28 | Myocardial infarction (HP:0001658) | 3.05422852 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.02900376 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01202953 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01202953 |
| 32 | Pulmonary infiltrates (HP:0002113) | 2.99455988 |
| 33 | Vasculitis (HP:0002633) | 2.94170906 |
| 34 | Encephalitis (HP:0002383) | 2.93576831 |
| 35 | Hemoptysis (HP:0002105) | 2.88772546 |
| 36 | Nephritis (HP:0000123) | 2.82313645 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80323839 |
| 38 | Pustule (HP:0200039) | 2.79996414 |
| 39 | Hypobetalipoproteinemia (HP:0003563) | 2.79605278 |
| 40 | Chest pain (HP:0100749) | 2.77784018 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.77150615 |
| 42 | Hematochezia (HP:0002573) | 2.72619257 |
| 43 | Joint hemorrhage (HP:0005261) | 2.72446907 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.71629869 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.70639786 |
| 46 | Esophageal varix (HP:0002040) | 2.70510030 |
| 47 | Abnormality of T cells (HP:0002843) | 2.69741963 |
| 48 | Gangrene (HP:0100758) | 2.68349823 |
| 49 | Leukocytosis (HP:0001974) | 2.67664313 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.66681002 |
| 51 | Hyperlipoproteinemia (HP:0010980) | 2.64362043 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.62803241 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.60413575 |
| 54 | Petechiae (HP:0000967) | 2.60212418 |
| 55 | Prolonged partial thromboplastin time (HP:0003645) | 2.59461097 |
| 56 | Hyperglycinuria (HP:0003108) | 2.57806376 |
| 57 | Episodic fever (HP:0001954) | 2.57571575 |
| 58 | Peritonitis (HP:0002586) | 2.51731473 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.51433336 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.49676258 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49676258 |
| 62 | Abnormal platelet volume (HP:0011876) | 2.49641837 |
| 63 | Colitis (HP:0002583) | 2.49134265 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.49033394 |
| 65 | Hyperammonemia (HP:0001987) | 2.47177407 |
| 66 | Anorexia (HP:0002039) | 2.46636181 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.40369679 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.40095325 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.39690157 |
| 70 | Recurrent skin infections (HP:0001581) | 2.38923979 |
| 71 | Axonal loss (HP:0003447) | 2.37390362 |
| 72 | Hypoglycemic coma (HP:0001325) | 2.37055597 |
| 73 | Increased IgM level (HP:0003496) | 2.36919563 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36768488 |
| 75 | Purpura (HP:0000979) | 2.35908473 |
| 76 | Myositis (HP:0100614) | 2.33352538 |
| 77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.32393656 |
| 78 | Recurrent viral infections (HP:0004429) | 2.31360820 |
| 79 | IgM deficiency (HP:0002850) | 2.30684373 |
| 80 | Fat malabsorption (HP:0002630) | 2.30220597 |
| 81 | Polycythemia (HP:0001901) | 2.29624033 |
| 82 | Nasal polyposis (HP:0100582) | 2.28799964 |
| 83 | Loss of speech (HP:0002371) | 2.26759310 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26058779 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26058779 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26058779 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 2.25566590 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 2.24645256 |
| 89 | Gingival bleeding (HP:0000225) | 2.24565780 |
| 90 | Hypolipoproteinemia (HP:0010981) | 2.24431507 |
| 91 | Cellulitis (HP:0100658) | 2.24358492 |
| 92 | Osteomyelitis (HP:0002754) | 2.23818241 |
| 93 | Gout (HP:0001997) | 2.23687041 |
| 94 | Chronic otitis media (HP:0000389) | 2.23110414 |
| 95 | Cerebral aneurysm (HP:0004944) | 2.21805951 |
| 96 | Joint swelling (HP:0001386) | 2.21259120 |
| 97 | Chronic diarrhea (HP:0002028) | 2.21206791 |
| 98 | Increased IgE level (HP:0003212) | 2.20208900 |
| 99 | Glomerulopathy (HP:0100820) | 2.20145127 |
| 100 | Granulocytopenia (HP:0001913) | 2.19377764 |
| 101 | Ketosis (HP:0001946) | 2.16953545 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.16695427 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 2.16695427 |
| 104 | Premature loss of primary teeth (HP:0006323) | 2.16401415 |
| 105 | Inflammation of the large intestine (HP:0002037) | 2.16328248 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15915445 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15915445 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15915445 |
| 109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15582950 |
| 110 | Eosinophilia (HP:0001880) | 2.15469965 |
| 111 | Abnormality of glycine metabolism (HP:0010895) | 2.12104352 |
| 112 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.12104352 |
| 113 | Abnormality of the intrinsic pathway (HP:0010989) | 2.11759012 |
| 114 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11575005 |
| 115 | Increased mean platelet volume (HP:0011877) | 2.10458794 |
| 116 | Amaurosis fugax (HP:0100576) | 2.08709727 |
| 117 | Epidermoid cyst (HP:0200040) | 2.08427569 |
| 118 | Gastrointestinal inflammation (HP:0004386) | 2.08027307 |
| 119 | Periodontitis (HP:0000704) | 2.07919066 |
| 120 | Hypoalphalipoproteinemia (HP:0003233) | 2.03863303 |
| 121 | Hemorrhage of the eye (HP:0011885) | 2.03677089 |
| 122 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01683909 |
| 123 | Abnormality of the pleura (HP:0002103) | 2.00831342 |
| 124 | Recurrent bronchitis (HP:0002837) | 2.00547622 |
| 125 | Abnormality of the prostate (HP:0008775) | 2.00534740 |
| 126 | Hypercholesterolemia (HP:0003124) | 2.00416686 |
| 127 | Vascular calcification (HP:0004934) | 1.99818165 |
| 128 | Skin ulcer (HP:0200042) | 1.99239735 |
| 129 | Abnormal platelet function (HP:0011869) | 1.98431259 |
| 130 | Impaired platelet aggregation (HP:0003540) | 1.98431259 |
| 131 | Hypergammaglobulinemia (HP:0010702) | 1.97766984 |
| 132 | Subacute progressive viral hepatitis (HP:0006572) | 1.97425002 |
| 133 | Polyneuropathy (HP:0001271) | 1.97264025 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94889729 |
| 135 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.94314296 |
| 136 | Thrombophlebitis (HP:0004418) | 1.94104521 |
| 137 | Arterial thrombosis (HP:0004420) | 1.93724155 |
| 138 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93588921 |
| 139 | Fatigue (HP:0012378) | 1.93059610 |
| 140 | Amyloidosis (HP:0011034) | 1.92672612 |
| 141 | Abnormality of the peritoneum (HP:0002585) | 1.92051175 |
| 142 | Urticaria (HP:0001025) | 1.91166400 |
| 143 | Gingivitis (HP:0000230) | 1.90472759 |
| 144 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89077484 |
| 145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88592345 |
| 146 | Abnormality of iron homeostasis (HP:0011031) | 1.87805652 |
| 147 | Hyperglycinemia (HP:0002154) | 1.87631717 |
| 148 | Epistaxis (HP:0000421) | 1.86770635 |
| 149 | Progressive neurologic deterioration (HP:0002344) | 1.86718589 |
| 150 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.86035653 |
| 151 | Abnormality of eosinophils (HP:0001879) | 1.85760493 |
| 152 | Hepatocellular carcinoma (HP:0001402) | 1.85410489 |
| 153 | Pulmonary embolism (HP:0002204) | 1.83689772 |
| 154 | Abnormality of T cell physiology (HP:0011840) | 1.83631386 |
| 155 | Orchitis (HP:0100796) | 1.82866659 |
| 156 | Acute hepatic failure (HP:0006554) | 1.80887409 |
| 157 | Menorrhagia (HP:0000132) | 1.79625887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.75223130 |
| 2 | ERN1 | 3.54943462 |
| 3 | TYK2 | 3.05744471 |
| 4 | FGFR4 | 2.84413915 |
| 5 | MAP4K1 | 2.68591350 |
| 6 | BMPR2 | 2.51391234 |
| 7 | TRIB3 | 2.44517091 |
| 8 | STK10 | 2.23040083 |
| 9 | BLK | 2.20192650 |
| 10 | TBK1 | 2.16860594 |
| 11 | PKN2 | 2.16272852 |
| 12 | EPHB1 | 2.13221102 |
| 13 | JAK3 | 2.08620670 |
| 14 | MAP3K14 | 2.06073268 |
| 15 | FES | 2.00662213 |
| 16 | CSF1R | 1.86517615 |
| 17 | ZAP70 | 1.86110169 |
| 18 | FGR | 1.83618280 |
| 19 | JAK1 | 1.81993381 |
| 20 | SIK1 | 1.81789786 |
| 21 | IRAK3 | 1.75717560 |
| 22 | PTK6 | 1.72998163 |
| 23 | BCKDK | 1.72690537 |
| 24 | PRPF4B | 1.70200952 |
| 25 | KDR | 1.64580318 |
| 26 | EEF2K | 1.60605768 |
| 27 | MAPK15 | 1.60296642 |
| 28 | EPHA3 | 1.56489026 |
| 29 | CSK | 1.52175951 |
| 30 | SIK3 | 1.50581362 |
| 31 | LRRK2 | 1.49882291 |
| 32 | MAP2K3 | 1.47942121 |
| 33 | MAP3K10 | 1.43929500 |
| 34 | IKBKE | 1.40620222 |
| 35 | ITK | 1.40124722 |
| 36 | MAP3K3 | 1.38637942 |
| 37 | IKBKB | 1.38113213 |
| 38 | MAP3K2 | 1.36867564 |
| 39 | FLT3 | 1.36527508 |
| 40 | GRK6 | 1.34905611 |
| 41 | TAOK3 | 1.31678406 |
| 42 | BTK | 1.30194041 |
| 43 | JAK2 | 1.27541122 |
| 44 | IRAK4 | 1.27501099 |
| 45 | NEK9 | 1.26300680 |
| 46 | FGFR3 | 1.22115426 |
| 47 | YES1 | 1.18644798 |
| 48 | IRAK2 | 1.18583648 |
| 49 | MAP3K13 | 1.17601726 |
| 50 | CAMK1D | 1.16956334 |
| 51 | KIT | 1.15364237 |
| 52 | TESK2 | 1.09420898 |
| 53 | PAK4 | 1.07723872 |
| 54 | MAP3K1 | 1.07697360 |
| 55 | TXK | 1.04160353 |
| 56 | MATK | 0.99722921 |
| 57 | MST1R | 0.98486880 |
| 58 | TAOK2 | 0.98080187 |
| 59 | CHUK | 0.97024959 |
| 60 | MAP3K12 | 0.96596781 |
| 61 | RPS6KA4 | 0.95318337 |
| 62 | TEC | 0.94913753 |
| 63 | STK24 | 0.94824197 |
| 64 | EPHA2 | 0.94822504 |
| 65 | HCK | 0.91835456 |
| 66 | RIPK1 | 0.89409648 |
| 67 | CDK6 | 0.89291082 |
| 68 | MST4 | 0.89006867 |
| 69 | PIM1 | 0.86614544 |
| 70 | NLK | 0.85762933 |
| 71 | MAPKAPK3 | 0.83512252 |
| 72 | LCK | 0.83297834 |
| 73 | MAPK11 | 0.81399634 |
| 74 | TNK2 | 0.81138563 |
| 75 | TGFBR1 | 0.79035813 |
| 76 | SYK | 0.76583161 |
| 77 | KSR2 | 0.76400066 |
| 78 | TAOK1 | 0.72331940 |
| 79 | MAP2K2 | 0.71109687 |
| 80 | TIE1 | 0.66069326 |
| 81 | MAP3K5 | 0.65058613 |
| 82 | PIK3CG | 0.64507825 |
| 83 | MAP3K6 | 0.64444851 |
| 84 | LYN | 0.64213575 |
| 85 | STK3 | 0.61674876 |
| 86 | NME2 | 0.61504037 |
| 87 | RIPK4 | 0.61469574 |
| 88 | MAP3K11 | 0.57979423 |
| 89 | FRK | 0.56487219 |
| 90 | PRKAA2 | 0.56007451 |
| 91 | CDK4 | 0.55759444 |
| 92 | MOS | 0.55559721 |
| 93 | MAP3K8 | 0.55453447 |
| 94 | ERBB3 | 0.55049088 |
| 95 | GSK3A | 0.54393883 |
| 96 | MARK3 | 0.54095428 |
| 97 | CDK12 | 0.53489042 |
| 98 | MAP3K7 | 0.52473059 |
| 99 | RPS6KB2 | 0.50209589 |
| 100 | RAF1 | 0.49067188 |
| 101 | PTK2B | 0.47277263 |
| 102 | EGFR | 0.46934093 |
| 103 | FYN | 0.46823072 |
| 104 | IRAK1 | 0.46800229 |
| 105 | PIM2 | 0.46280448 |
| 106 | KSR1 | 0.44071325 |
| 107 | FER | 0.43973099 |
| 108 | PRKCQ | 0.43724523 |
| 109 | DYRK1B | 0.43697168 |
| 110 | GRK7 | 0.43503987 |
| 111 | IGF1R | 0.43181069 |
| 112 | MAPKAPK2 | 0.42191552 |
| 113 | TRPM7 | 0.41895215 |
| 114 | PDPK1 | 0.41250364 |
| 115 | STK4 | 0.40780555 |
| 116 | PTK2 | 0.40635383 |
| 117 | CAMK1G | 0.37667698 |
| 118 | PDGFRB | 0.37441006 |
| 119 | ABL1 | 0.35832292 |
| 120 | SCYL2 | 0.35453456 |
| 121 | PDK1 | 0.35191106 |
| 122 | MAPK7 | 0.32497446 |
| 123 | MTOR | 0.31739875 |
| 124 | PRKG2 | 0.31563474 |
| 125 | MAPK4 | 0.30845901 |
| 126 | CAMKK2 | 0.30641259 |
| 127 | MELK | 0.30569161 |
| 128 | ACVR1B | 0.29712542 |
| 129 | MAPK12 | 0.29174193 |
| 130 | RET | 0.28896834 |
| 131 | PRKCD | 0.27284619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.21101043 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.84669415 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.59490327 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.58465571 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54243977 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.39923782 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.39754833 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36484725 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.21195287 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03976249 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.00440634 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94070609 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.92480577 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.91970990 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.89670329 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85672544 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69672836 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63748389 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58123740 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57390635 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54334824 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50939928 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49471419 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.48255497 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47836595 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.47054882 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46817569 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42829984 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.32658854 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.28331190 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.28172673 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27650510 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26562547 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26242477 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25559586 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.25084079 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23371430 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21893887 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.20179269 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19275339 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19119552 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.18524516 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17729560 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13713695 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13598866 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.12767722 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12204935 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11089469 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10340582 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08501069 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08313069 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07722054 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06638855 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04753078 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.04552786 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04266801 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04038605 |
| 58 | Measles_Homo sapiens_hsa05162 | 1.02575711 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01799031 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01297857 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01275295 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01122627 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99570513 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98657529 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98037110 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.92556138 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92304176 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91687705 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90035326 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89677009 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87898995 |
| 72 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87652192 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87057423 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85513427 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84009569 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81713923 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.79446303 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77991993 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.77861108 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77333124 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77208070 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77121618 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77118718 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75093594 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72870347 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72327104 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71133197 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.70966234 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70804232 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.70694724 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70479626 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70082518 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68752653 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.67286309 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65774891 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65588501 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65387898 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65258484 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64791904 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64749900 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64158164 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64051377 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.64049908 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63692678 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.63539119 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62668643 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62017300 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.61495614 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.59964743 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59302394 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58779519 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58413744 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57939913 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57529850 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55579666 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.55225147 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54085987 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51639033 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51396602 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50369662 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49943253 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49787476 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49599698 |
| 124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49121244 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.48412469 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.47285622 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46997419 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46455282 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45741392 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45692970 |
| 131 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45551659 |
| 132 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44908603 |
| 133 | Shigellosis_Homo sapiens_hsa05131 | 0.44831424 |
| 134 | Allograft rejection_Homo sapiens_hsa05330 | 0.44828829 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.44756410 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44183101 |
| 137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42434759 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40776822 |
| 139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38666919 |
| 140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36589569 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36581522 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32662837 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29918640 |
| 144 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28582497 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.24788564 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22589377 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22479425 |
| 148 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21391001 |
| 149 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20108359 |

